HIT Consultant January 23, 2024
Jasmine Pennic

What You Should Know:

Thirona, a pioneer in AI-powered lung analysis, received a major boost for its cutting-edge technology LungQ™ with the U.S. Food and Drug Administration (FDA) 510(k) clearance for its latest update, v3.0.0.

– This FDA clearance paves the way for American hospitals to now harness the software’s advanced capabilities, marking a significant step forward in lung disease diagnosis and treatment.

LungQ 3.0.0: Precision Navigation for Lung Interventions

This latest iteration stands out as one of the few FDA-cleared solutions capable of automatically segmenting and analyzing the intricate landscape of the lungs’ internal anatomy. Its AI prowess goes beyond mere mapping; it identifies key structures like lobes, segments, subsegments, airways, and fissures, allowing for:

  • Detailed tissue...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Provider, Technology
AI Investments Expected to Shift to Inference While Growing Faster Than Forecast
The most 'impactful' tech in 30 years? Ask Duke's health information chief
AI-Based GPS Without Satellites: The Future Of Navigation
AI that can match humans at any task will be here in five to 10 years, Google DeepMind CEO says
Fluency Isn’t Intelligence in Healthcare

Share This Article